Third International Study on Mechanical Ventilation

NCT01093482 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 8151

Last updated 2018-03-01

Study results available
· View outcomes & findings →

Summary

The objective of this study is to obtain a better understanding of the spectrum of use of mechanical ventilation in intensive care units:

1. Main analysis: To know the all-cause mortality rate in mechanically ventilated patients
2. Secondary analyses:

* To know the current status of mechanical ventilation in the intensive care unit and determine the number and percentage of patients who are admitted to an intensive care unit and require mechanical ventilation.
* To compare the results with prior data collected in previous observational studies (1998 and 2004)
* Non-invasive positive pressure ventilation
* Weaning
* Use of adjuvant therapies as steroids or selective digestive decontamination
* Sedation including prevalence of delirium in mechanically ventilated patients
* Prediction of the duration of mechanical ventilation
* Other

Conditions

  • Acute Respiratory Failure

Sponsors & Collaborators

  • Hospital Universitario Getafe

    lead OTHER

Principal Investigators

  • Andres Esteban, MD, PhD · Hospital Universitario de Getafe, Spain

  • Fernando Frutos-Vivar, MD · Hospital Universitario de Getafe, Spain

  • Niall D Ferguson, MD, MsC · University of Toronto, Ontario, Canada

  • Antonio Anzueto, MD · University of Texas Health Science Center, San Antonio, Texas, USA

  • Marco González, MD · Clinica Medellin & Universidad Pontificia Bolivariana, Colombia

  • Arnaud W Thille, MD · AP-HP, Centre Hospitalier Albert Chenevier, Henri Mondor, Créteil, France

  • Konstantinos Raymondos, MD · Hannover Medical School

  • Salvatore Maggiore, MD · Agostino Gemelli University Hospital, Università Cattolica del Sacro Cuore, Rome, Italy

  • Yaseen Arabi, MD · King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia

  • Rui Moreno, MD · Hospital de Santo António dos Capuchos, Lisboa, Portugal

  • Fekri Abroug, MD · Fattouma Bourguiba, Monastir, Tunisia

  • Javier Hurtado, MD · Hospital de Clínicas, Montevideo, Uruguay

  • Fernando Rios, MD · Hospital A.Posadas, Buenos Aires, Argentina

  • Luis Soto, MD · Hospital Nacional del Tórax, Santiago, Chile

  • Damian Violi, MD · Hospital HIGA, Güemes, Argentina

  • Jasmine Board, MD · Alfred Hospital, Melbourne, Australia

  • Andrew Davies, MD · Alfred Hospital, Melbourne, Australia

  • Fredi Sandi Lora, MD · Hospital Obrero Número 1, La Paz, Bolivia

  • Marco Antonio Soares Reis, MD · Hospital Universitário São José, Belo Horizonte, Brazil

  • Bin Du, MD · Peking Union Medical College Hospital, Beijing, Popular Republic of China

  • Hans-Henrik Bülow, MD · Holbak, Denmark

  • Manuel Jibaja, MD · Hospital Militar de Quito, Ecuador

  • Dimitros Matamis, MD · Papageorgiou Hospital, Thessaloniki, Greece

  • Younsuck Koh, MD · Asan Medical Center, University of Ulsan, Seoul, Korea

  • Asisclo Villagómez, MD · Hospital Regional 1° de Octubre, ISSSTE, México DF, Mexico

  • Amine Ali Zeggwagh, MD · Hôpital Ibn Sina, Rabat, Morocco

  • Michael Kuiper, MD · Medical Center Leeuwarden (MCL), Leeuwarden, The Netherlands

  • Edward Nicolayenko, MD · Hospital No.1, Moscow, Russian Federation

  • Nicolas Nin, MD · Hospital Universitario de Getafe, Spain

  • Nahit Cakar, MD · Istanbul Medical Faculty, Istanbul, Turkey

  • Gabriel D'Empaire, MD · Hospital de Clinicas de Caracas, Venezuela

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-04-30
Primary Completion
2010-07-31
Completion
2010-09-30

Countries

  • United States
  • Argentina
  • Australia
  • Bolivia
  • Brazil
  • Canada
  • Chile
  • China
  • Colombia
  • Denmark
  • Ecuador
  • Egypt
  • France
  • Germany
  • Greece
  • Hungary
  • India
  • Italy
  • Japan
  • Mexico
  • Morocco
  • Netherlands
  • New Zealand
  • Panama
  • Peru
  • Poland
  • Portugal
  • Puerto Rico
  • Russia
  • Saudi Arabia
  • South Korea
  • Spain
  • Taiwan
  • Tunisia
  • Turkey (Türkiye)
  • Uruguay
  • Venezuela
  • Vietnam

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01093482 on ClinicalTrials.gov